Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial (2013)
- Authors:
- Steg, Philippe Gabriel
- Mehta, Shamir R.
- Pollack Jr, Charles V.
- Bode, Christoph
- Cohen, Marc
- French, William J.
- Hoekstra, James
- Rao, Sunil V.
- Ruzyllo, Witold
- Ruiz-Nodar, Juan M.
- Sabaté, Manel
- Widimsky, Petr
- Kiss, Robert Gabor
- Estrada, Jose Luis Navarro
- Hod, Hanoch
- Kerkar, Prafulla
- Guneri, Sema
- Sezer, Murat
- Ruda, Mikhail
- Nicolau, José Carlos
- Cavallini, Claudio
- Ebrahim, Iftikhar
- Petrov, Ivo
- Kim, Jae-Hyung
- Jeong, Myung-Ho
- Lopez, Gabriel Arturo Ramos
- Laanmets, Peep
- Kovar, Frantisek
- Gaudin, Christophe
- Fanouillere, Karen C.
- Minini, Pascal
- Hoffman, Elaine B.
- Moryusef, Angele
- Wiviott, Stephen D.
- Sabatine, Marc S.
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1001/jama.2013.277165
- Subjects: ANTICOAGULANTES; ISQUEMIA; DOENÇA AGUDA; CORONARIOPATIA (TERAPIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: JAMA: Journal of the American Medical Association
- ISSN: 0098-7484
- Volume/Número/Paginação/Ano: v. 310, n. 11, p. 1145-1155, 2013
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
STEG, Philippe Gabriel et al. Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial. JAMA: Journal of the American Medical Association, v. 310, n. 11, p. 1145-1155, 2013Tradução . . Disponível em: https://doi.org/10.1001/jama.2013.277165. Acesso em: 06 fev. 2026. -
APA
Steg, P. G., Mehta, S. R., Pollack Jr, C. V., Bode, C., Cohen, M., French, W. J., et al. (2013). Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial. JAMA: Journal of the American Medical Association, 310( 11), 1145-1155. doi:10.1001/jama.2013.277165 -
NLM
Steg PG, Mehta SR, Pollack Jr CV, Bode C, Cohen M, French WJ, Hoekstra J, Rao SV, Ruzyllo W, Ruiz-Nodar JM, Sabaté M, Widimsky P, Kiss RG, Estrada JLN, Hod H, Kerkar P, Guneri S, Sezer M, Ruda M, Nicolau JC, Cavallini C, Ebrahim I, Petrov I, Kim J-H, Jeong M-H, Lopez GAR, Laanmets P, Kovar F, Gaudin C, Fanouillere KC, Minini P, Hoffman EB, Moryusef A, Wiviott SD, Sabatine MS. Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial [Internet]. JAMA: Journal of the American Medical Association. 2013 ; 310( 11): 1145-1155.[citado 2026 fev. 06 ] Available from: https://doi.org/10.1001/jama.2013.277165 -
Vancouver
Steg PG, Mehta SR, Pollack Jr CV, Bode C, Cohen M, French WJ, Hoekstra J, Rao SV, Ruzyllo W, Ruiz-Nodar JM, Sabaté M, Widimsky P, Kiss RG, Estrada JLN, Hod H, Kerkar P, Guneri S, Sezer M, Ruda M, Nicolau JC, Cavallini C, Ebrahim I, Petrov I, Kim J-H, Jeong M-H, Lopez GAR, Laanmets P, Kovar F, Gaudin C, Fanouillere KC, Minini P, Hoffman EB, Moryusef A, Wiviott SD, Sabatine MS. Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial [Internet]. JAMA: Journal of the American Medical Association. 2013 ; 310( 11): 1145-1155.[citado 2026 fev. 06 ] Available from: https://doi.org/10.1001/jama.2013.277165 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
- Urgent revascularization strategies in patients with diabetes mellitus and acute coronary syndrome
Informações sobre o DOI: 10.1001/jama.2013.277165 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas